Are Time-Release Implants an Effective Treatment for Uveitis?

August 24, 2011

A team of researchers The Mount Sinai Medical Center lead by Dr. Douglas A. Jabs recently published the outcome of a study (the Multicenter Uveitis Steroid Treatment (MUST) Trial), comparing the two leading treatment approaches for uveitis.

The researchers found that a time-release corticosteroid implant placed surgically in the eye (which slowly releases corticosteroid medication over a period of up to three years) is similarly effective in treating the disease as anti-inflammatory corticosteroids and immunosuppressive drugs taken orally.

The FDA approved the intraocular implant for treatment of uveitis in 2005.

Click here to read the full release announcing the results of the study.




Jump down to form below to submit your own comments

Comments are closed.